Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-004559
Filing Date
2025-02-13
Accepted
2025-02-13 12:08:27
Documents
1
Period of Report
2025-02-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 13844
  Complete submission text file 0001127602-25-004559.txt   15497
Mailing Address 358 S MAIN ST BURLINGTON NC 27215
Business Address 358 S MAIN ST BURLINGTON NC 27215 3362291127
LABCORP HOLDINGS INC. (Issuer) CIK: 0000920148 (see all company filings)

EIN.: 992588107 | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O PHARMACEUTICAL PRODUCT DEVELOPMENT 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
Wilkinson Peter J (Reporting) CIK: 0001398138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11353 | Film No.: 25618513